etravirine has been researched along with Dyslipidemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calmy, A; Cavassini, M; Ciaffi, L; Delhumeau, C; Fehr, J; Genne, D; Hill, A; Hirschel, B; Montecucco, F; Schmid, P; Spycher Elbes, R; Stoeckle, M; Wandeler, G | 1 |
Portilla, J | 1 |
Domingo, P | 1 |
2 review(s) available for etravirine and Dyslipidemia
Article | Year |
---|---|
[Safety and tolerability of etravirine].
Topics: Animals; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Drug Eruptions; Drug Evaluation, Preclinical; Dyslipidemias; Female; Fetus; Gastrointestinal Diseases; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides | 2009 |
[Role of etravirine in combination antiretroviral therapy].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Interactions; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2009 |
1 trial(s) available for etravirine and Dyslipidemia
Article | Year |
---|---|
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.
Topics: Adolescent; Adult; Aged; Alkynes; Benzoxazines; Biomarkers; Cardiovascular Diseases; Cyclopropanes; Drug Substitution; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Middle Aged; Nitriles; Prospective Studies; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Young Adult | 2015 |